The Role of LncRNAs in B-cell Malignancies
سال انتشار: 1397
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 469
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
این مقاله در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
AMSMED19_373
تاریخ نمایه سازی: 1 دی 1397
چکیده مقاله:
Background and Objective: Multiple myeloma is another example of B-cell malignancies and accounts for more than 1% of all cancers. Evidence suggests that non-coding RNAs undoubtedly have an undeniable function in hematological malignancies, such as multiple myeloma Evidence suggests that non-coding RNAs undoubtedly have an undeniable function in hematological malignancies, such as multiple myeloma. In these abnormalities, by use of replacement or inhibition of non-coding RNAs is emerging as a new novel way in treatment. In this review, we focus on long non-coding RNAs (lncRNAs) that are involved in multiple myeloma. We define the long non coding RNAs and indicate multiple myeloma-inclined list of lncRNAs, and describe some of the role of lncRNAs in cancer, as well as current and future research programs for lncRNAs for the treatment of cancers, especially multiple myeloma. Materials and Methods: PubMed, Scopusand Google Scholar were searched fromJanuary 2013 to December 2017. Based on inclusion and exclusion criteria ten relevant experimental studies with moderate bias were selected. The effect of the role of LncRNAs in B-cell malignancies was evaluated. Findings: Our analysis showed that the presently available evidence confirmed the therapeutic potential of LncRNAs in significantly Inhibition and improvement of B-cell malignancy symptoms. Conclusions: LncRNAs are an emerging field of investigation as they are suggested to regulate key biological processes, including cellular proliferation and differentiation, and their aberrant expression being strongly associated with cancer. An improved understanding of the role of ncRNAs in multiple myeloma would provide valuable information about key cancer-promoting pathways and might be highly useful for diagnostic and prognostic assessments. This knowledge might also lead to advancement in the management of multiple myeloma through the development of novel personalized ncRNA-based therapies.
کلیدواژه ها:
نویسندگان
Reza Gheitasi
MSc student of immunology, Students Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.
Hamed Manoochehry
Ph.D student of medical biotechnology, Students Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.
Masoumeh Beig
MSc student of Microbiology, Students Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.